J
Jackie F. Price Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
High Impact
Researcher
faculty
85 h-index
395 pubs
64,319 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Jackie F. Price is a researcher at the University of Arkansas at Pine Bluff, leading a research group and holding a highly cited designation. Their work centers on understanding the genetic and physiological factors influencing chronic diseases, particularly type 2 diabetes and cardiovascular disease. Price has published extensively on topics including the association between age at diagnosis and life expectancy in type 2 diabetes, and the role of specific genetic variations in cardiovascular risk.
Further research areas include the investigation of biomarkers and therapeutic targets for cardiovascular disease, such as the cholesteryl ester transfer protein (CETP). Price's publications also address the relationship between retinal vascular characteristics and long-term cardiovascular outcomes in individuals with type 2 diabetes. This work contributes to a broader understanding of disease progression and potential intervention points.
With a substantial publication record and high citation count (h-index: 86, total publications: 395, total citations: 65,811), Price's research network includes collaborators such as Adedeji O. Adetunji, Emmanuel Asiamah, Shahidul Islam, and Henrietta Owusu, all from the University of Arkansas at Pine Bluff.
Metrics
- h-index: 85
- Publications: 395
- Citations: 64,319
Selected Publications
-
Correction: Mechanisms by which phytogenic extracts enhance livestock reproductive health: current insights and future directions (2025)
-
Mechanisms by which phytogenic extracts enhance livestock reproductive health: current insights and future directions (2025)
Collaboration Network
Top Collaborators
Pimphen Charoen
8 shared publications
- Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
- Triangulating evidence from observational and Mendelian randomization studies of ketone bodies for cognitive performance
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins
Showing 5 of 8 shared publications
Mika Kivimäki
8 shared publications
- Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
- Triangulating evidence from observational and Mendelian randomization studies of ketone bodies for cognitive performance
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins
Showing 5 of 8 shared publications
Tom R. Gaunt
8 shared publications
- Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
- Triangulating evidence from observational and Mendelian randomization studies of ketone bodies for cognitive performance
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins
Showing 5 of 8 shared publications
Aroon D. Hingorani
8 shared publications
- Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
- Triangulating evidence from observational and Mendelian randomization studies of ketone bodies for cognitive performance
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins
Showing 5 of 8 shared publications
Chris Finan
8 shared publications
- Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
Showing 5 of 8 shared publications
Amand F. Schmidt
British Heart Foundation (GB)
7 shared publications
- Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
- Triangulating evidence from observational and Mendelian randomization studies of ketone bodies for cognitive performance
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins
Showing 5 of 7 shared publications
Fotios Drenos
7 shared publications
- Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
Showing 5 of 7 shared publications
Debbie A. Lawlor
7 shared publications
- Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
Showing 5 of 7 shared publications
S. Goya Wannamethee
7 shared publications
- Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
Showing 5 of 7 shared publications
Andrew Wong
University College London (GB)
7 shared publications
- Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
- Triangulating evidence from observational and Mendelian randomization studies of ketone bodies for cognitive performance
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins
Showing 5 of 7 shared publications
Alun D. Hughes
7 shared publications
- Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
Showing 5 of 7 shared publications
Stela McLachlan
University of Edinburgh (GB)
7 shared publications
- Genome-Wide Association Study of Peripheral Artery Disease
- Retinal venular tortuosity and fractal dimension predict incident retinopathy in adults with type 2 diabetes: the Edinburgh Type 2 Diabetes Study
- Retinal arteriolar tortuosity and fractal dimension are associated with long-term cardiovascular outcomes in people with type 2 diabetes
- Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh Type 2 Diabetes Study
- Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes
Showing 5 of 7 shared publications
Mark W. J. Strachan
Western General Hospital (GB)
7 shared publications
- Retinal venular tortuosity and fractal dimension predict incident retinopathy in adults with type 2 diabetes: the Edinburgh Type 2 Diabetes Study
- Retinal arteriolar tortuosity and fractal dimension are associated with long-term cardiovascular outcomes in people with type 2 diabetes
- Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh Type 2 Diabetes Study
- Combining serum metabolomic profiles with traditional risk factors improves 10-year cardiovascular risk prediction in people with type 2 diabetes
- Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes
Showing 5 of 7 shared publications
María Gordillo‐Marañón
6 shared publications
- Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins
- Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
Showing 5 of 6 shared publications
Claudia Giambartolomei
6 shared publications
- Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins
- Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins
- Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
Showing 5 of 6 shared publications
Similar Researchers
Based on overlapping research topics
Syeda Naqvi
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Cardiovascular Function and Risk Factors
Diabetes Management and Research
Steven Webber
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Cardiovascular Function and Risk Factors
Genomics and Phylogenetic Studies
Marina Joseph
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Cardiovascular Function and Risk Factors
Diabetes Management and Research
Grant Robinson
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Cardiovascular Function and Risk Factors
Health disparities and outcomes
Hannah Campbell
University of Central Arkansas
Metabolism and Genetic Disorders
Cardiovascular Function and Risk Factors
Genomics and Phylogenetic Studies
Meena Chatrathi
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Cardiovascular Function and Risk Factors
Diabetes Management and Research